RACGP raises safety questions on new anticoagulants

THE RACGP has voiced concern over the speed of the rollout of new generation anticoagulants and the associated “pressure” for subsidy.

Please Login to Access Medical Observer

If you have an account select Login. If you are new to Medical Observer select Join.

Login Join


Staff Writer

News and features from Medical Observer's writers and editors.